Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other financing activities (as filed) (2024 - 2026)

Updated

Adaptin Bio's Other financing activities (as filed) was -$109,763 in Q2 2026.

Analysis

Adaptin Bio (APTN) Other financing activities (as filed) (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Adaptin Bio's Other financing activities (as filed) was -$740,368 through Jun 30, 2026; for FY2025, it came in at -$1.68 million.

  • In earlier years, Other financing activities (as filed) was -$321,386 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -109,763.00
Mar 31, 2026 -213,567.00
Dec 31, 2025 -417,038.00
Mar 31, 2025 -1.27 Mn
Dec 31, 2024 -193,876.00
API Access

Adaptin Bio Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=APTN&period=max&api_key=YOUR_API_KEY